netFormulary
 Report : A-Z HCD items in Formulary 05/06/2020 16:29:53
[Back]
 
Section Status HCD Name
10.01.03 Formulary Cancer Drugs Fund Abatacept Orencia
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga
01.05.03 Formulary Cancer Drugs Fund Adalimumab Humira
10.01.03 Formulary Cancer Drugs Fund Adalimumab Humira
11.99.99.99 Formulary Cancer Drugs Fund Adalimumab 
13.05.03 Formulary Cancer Drugs Fund Adalimumab Humira
05.03.03.01 Formulary Cancer Drugs Fund Adefovir Dipivoxil Hepsera
08.01.05 Non Formulary Cancer Drugs Fund Aflibercept Zaltrap
11.08.02 Formulary Cancer Drugs Fund Aflibercept Eylea
09.08.01 Non Formulary Cancer Drugs Fund Agalsidase Alfa and Beta Fabrazyme
09.08.01 Non Formulary Cancer Drugs Fund Agalsidase Alfa and Beta Replagal
08.02.04 Formulary Cancer Drugs Fund Aldesleukin Proleukin
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab Lemtrada
09.08.01 Non Formulary Cancer Drugs Fund Alglucosidase Alfa Myozyme
02.12 Formulary Cancer Drugs Fund Alirocumab Praluent
13.05.01 Formulary Cancer Drugs Fund Alitretinoin Toctino
02.05.01 Non Formulary Cancer Drugs Fund Ambrisentan 
05.02 Non Formulary Cancer Drugs Fund Amphotericin Abelcet
05.02 Formulary Cancer Drugs Fund Amphotericin AmBisome
10.01.03 Restricted Use Cancer Drugs Fund Anakinra Kineret
05.02.04 Non Formulary Cancer Drugs Fund Anidulafungin Ecalta
02.11 Formulary Cancer Drugs Fund Antithrombin III Kybemin
08.02.02 Non Formulary Cancer Drugs Fund Antithymocyte immunoglobulin (Rabbit)  Thymoglobuline
09.01.03 Formulary Cancer Drugs Fund Antithymocyte Immunoglobulin (Rabbit)  
13.05.03 Formulary Cancer Drugs Fund Apremilast Otezla
10.02 Formulary Cancer Drugs Fund Ataluren Translarna
05.03.01 Formulary Cancer Drugs Fund Atazanavir Reyataz
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio
08.01.05 Formulary Cancer Drugs Fund Axitinib Inlyta
08.01.03 Formulary Cancer Drugs Fund Azacitidine Vidaza
05.01.02.03 Non Formulary Cancer Drugs Fund Aztreonam nebuliser solution Cayston
10.01.03 Formulary Cancer Drugs Fund Baricitinib Olumiant
08.02.02 Formulary Cancer Drugs Fund Basiliximab Simulect
05.01.09 Formulary Cancer Drugs Fund Bedaquiline Sirturo
08.02.02 Formulary Cancer Drugs Fund Belatacept Nulojix
10.01 Formulary Cancer Drugs Fund Belimumab Benlysta
08.01.01 Formulary Cancer Drugs Fund Bendamustine Levact
03.05.02 Non Formulary Cancer Drugs Fund Beractant Survanta
05.03.03.02 Formulary Cancer Drugs Fund Boceprevir Victrelis
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
02.05.01 Non Formulary Cancer Drugs Fund Bosentan Tracleer
04.07.04.02 Formulary Cancer Drugs Fund Botulinum Toxin Type A 
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
13.05.03 Formulary Cancer Drugs Fund Brodalumab Kyntheum
10.01.03 Formulary Cancer Drugs Fund Burosumab Crysvita
03.04.03 Non Formulary Cancer Drugs Fund C1 esterase inhibitor Cinryze
03.04.03 Non Formulary Cancer Drugs Fund C1 Esterase Inhibitor Berinert
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cabometyx
08.02.04 Non Formulary Cancer Drugs Fund Canakinumab Ilaris
09.08.01 Non Formulary Cancer Drugs Fund Carglumic Acid Carbaglu
05.02.04 Non Formulary Cancer Drugs Fund Caspofungin Cancidas
02.11 Non Formulary Cancer Drugs Fund Catridecacog NovoThirteen
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol Cimzia
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux
08.02.02 Formulary Cancer Drugs Fund Ciclosporin 
05.03.02.02 Non Formulary Cancer Drugs Fund Cidofovir infusion Vistide
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra
05.03.01 Non Formulary Cancer Drugs Fund Cobicistat Tybost
04.09.01 Non Formulary Cancer Drugs Fund Co-Careldopa Intestinal gel Duodopa
09.05.02.02 Non Formulary Cancer Drugs Fund Colestilan BindRen
03.04.03 Formulary Cancer Drugs Fund Conestat Alfa Ruconest
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar
05.03.03.02 Formulary Cancer Drugs Fund Daclatasvir  Daklinza
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex
09.01.03 Formulary Cancer Drugs Fund Darbepoetin alfa Aranesp
05.03.01 Formulary Cancer Drugs Fund Darunavir Prezista
05.03.03.02 Formulary Cancer Drugs Fund Dasabuvir Exviera
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
20 Non Formulary Cancer Drugs Fund DAUNORUBICIN saline pre-filled syringe 
08.01.03 Non Formulary Cancer Drugs Fund Decitabine Dacogen
09.01.03 Formulary Cancer Drugs Fund Deferasirox Exjade
09.01.03 Formulary Cancer Drugs Fund Deferiprone Ferriprox
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Capsules 400 mg 
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Injection 200 mg 
05.01.09 Formulary Cancer Drugs Fund Delamanid Deltyba
11.04.01 Formulary Cancer Drugs Fund Dexamethasone Intravitreal Implant Ozurdex
08.01 Formulary Cancer Drugs Fund Dexrazoxane Savene
02.01.01 Formulary Cancer Drugs Fund Digoxin specific antibody fragments Digifab
08.02.04 Formulary Cancer Drugs Fund Dimethyl fumarate Tecfidera
13.05.03 Formulary Cancer Drugs Fund Dimethyl fumarate Skilarence
05.03.01 Formulary Cancer Drugs Fund Dolutegravir Tivicay
05.03.01 Formulary Cancer Drugs Fund Dolutegravir, abacavir & lamivudine Triumeq
03.07 Formulary Cancer Drugs Fund Dornase Alfa Pulmozyme
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx
13.05.03 Formulary Cancer Drugs Fund Dupilumab Dupixent
09.01.03 Formulary Cancer Drugs Fund Eculizumab Soliris
05.03.01 Formulary Cancer Drugs Fund Efavirenz Sustiva
09.08.01 Non Formulary Cancer Drugs Fund Eliglustat Cerdelga
09.01.04 Formulary Cancer Drugs Fund Eltrombopag Revolade
05.03.01 Formulary Cancer Drugs Fund Enfuvirtide Fuzeon
05.03.03.01 Formulary Cancer Drugs Fund Entecavir Baraclude
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi
09.01.03 Formulary Cancer Drugs Fund Epoetin alfa Eprex
09.01.03 Formulary Cancer Drugs Fund Epoetin beta NeoRecormon
09.01.03 Non Formulary Cancer Drugs Fund Epoetin zeta Retacrit
02.08.01 Formulary Cancer Drugs Fund Epoprostenol Flolan
20 Non Formulary Cancer Drugs Fund Eptotermin Alfa  Osigraft
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Formulary Cancer Drugs Fund Erlotinib Tarceva
10.01.03 Formulary Cancer Drugs Fund Etanercept Enbrel
13.05.03 Formulary Cancer Drugs Fund Etanercept 
05.03.01 Formulary Cancer Drugs Fund Etravirine Intelence
08.01.05 Formulary Cancer Drugs Fund Everolimus 
02.12 Formulary Cancer Drugs Fund Evolocumab Repatha
02.11 Formulary Cancer Drugs Fund Factor IX Fraction, Dried 
02.11 Formulary Cancer Drugs Fund Factor VIIa (Recombinant) Novo 7
02.11 Formulary Cancer Drugs Fund Factor VIII Fraction, Dried 
02.11 Formulary Cancer Drugs Fund Factor VIII Inhibitor Bypassing Fraction (FEIBA) 
02.11 Formulary Cancer Drugs Fund Factor XIII Fraction, Dried 
08.02.04 Non Formulary Cancer Drugs Fund Fampridine 
09.01.06 Formulary Cancer Drugs Fund Filgrastim 
08.02.04 Formulary Cancer Drugs Fund Fingolimod 
11.04.01 Formulary Cancer Drugs Fund Fluocinolone Acetonide Intravitreal Implant Iluvien
18 Non Formulary Cancer Drugs Fund Fomepizole 
05.03.01 Formulary Cancer Drugs Fund Fosamprenavir Telzir
05.03.02.02 Formulary Cancer Drugs Fund Foscarnet Sodium Foscavir
05.03.02.02 Formulary Cancer Drugs Fund Ganciclovir Cymevene
08.01.05 Formulary Cancer Drugs Fund Gefitinib Iressa
08.02.04 Formulary Cancer Drugs Fund Glatiramer Acetate Copaxone
18 Non Formulary Cancer Drugs Fund Glucarpidase Carboxypeptidase
01.05.03 Formulary Cancer Drugs Fund Golimumab Simponi
10.01.03 Formulary Cancer Drugs Fund Golimumab Simponi
13.05.03 Formulary Cancer Drugs Fund Guselkumab Tremfya
09.08.02 Formulary Cancer Drugs Fund Haem Arginate Normosang
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
03.04.03 Non Formulary Cancer Drugs Fund Icatibant Firazyr
02.05.01 Formulary Cancer Drugs Fund Iloprost injection  
08.01.05 Non Formulary Cancer Drugs Fund Imatinib Gilvec
08.01.05 Formulary Cancer Drugs Fund Imatinib Gilvec
09.08.01 Non Formulary Cancer Drugs Fund Imiglucerase Cerezyme
05.03.01 Formulary Cancer Drugs Fund Indinavir Crixivan
01.05.03 Formulary Cancer Drugs Fund Infliximab 
10.01.03 Formulary Cancer Drugs Fund Infliximab 
13.05.03 Formulary Cancer Drugs Fund Infliximab Remicade
09.08.01 Formulary Cancer Drugs Fund Inotersen Tegsedi
08.02.04 Non Formulary Cancer Drugs Fund Interferon Alfa 
08.02.04 Non Formulary Cancer Drugs Fund Interferon Alfa Roferon-A
08.02.04 Non Formulary Cancer Drugs Fund Interferon Alfa Viraferon
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy
03.07 Formulary Cancer Drugs Fund Ivacaftor 
10.01.03 Formulary Cancer Drugs Fund Ixekizumab Taltz
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide  Somatuline Autogel
09.05.02.02 Formulary Cancer Drugs Fund Lanthanum Fosrenol
08.01.05 Non Formulary Cancer Drugs Fund Lapatinib Tyverb
09.08.01 Non Formulary Cancer Drugs Fund Laronidase Aldurazyme
05.03.03.02 Formulary Cancer Drugs Fund Ledipasvir and Sofosbuvir Harvoni
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid
09.01.06 Formulary Cancer Drugs Fund Lenograstim Granocyte
09.08.01 Formulary Cancer Drugs Fund Levocarnitine Carnitor
05.01.12 Formulary Cancer Drugs Fund Levofloxacin Quinsair
09.01.06 Non Formulary Cancer Drugs Fund Lipegfilgrastim  Lonquex
02.12 Non Formulary Cancer Drugs Fund Lomitapide Lojuxta
05.03.01 Formulary Cancer Drugs Fund Lopinavir and Ritonavir Kaletra
02.05.01 Formulary Cancer Drugs Fund Macitentan Opsumit
03.07 Formulary Cancer Drugs Fund Mannitol dry powder for inhalation 
05.03.01 Formulary Cancer Drugs Fund Maraviroc Celsentri
06.07.04 Non Formulary Cancer Drugs Fund Mecasermin Increlex
09.08.01 Non Formulary Cancer Drugs Fund Mercaptamine (Cysteamine) Cystagon
09.01.03 Formulary Cancer Drugs Fund Methoxy Polyethylene Glycol-Epoetin Beta Mircera
05.02.04 Formulary Cancer Drugs Fund Micafungin Mycamine
09.08.01 Non Formulary Cancer Drugs Fund Miglustat Zavesca
08.02.04 Formulary Cancer Drugs Fund Natalizumab Tysabri
08.01.05 Non Formulary Cancer Drugs Fund Necitumumab Portrazza
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance
05.03.01 Formulary Cancer Drugs Fund Nevirapine Viramune
08.01.05 Formulary Cancer Drugs Fund Nilotinib Tasigna
03.11 Formulary Cancer Drugs Fund Nintedanib Ofev
08.01.05 Formulary Cancer Drugs Fund Nintedanib  Vargatef
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin Vigam
14.05.01 Formulary Cancer Drugs Fund Normal immunoglobulin Privigen
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin Gammagard S/D
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro
11.08.02 Formulary Cancer Drugs Fund Ocriplasmin Jetrea
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin LAR
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin
08.02.03 Formulary Cancer Drugs Fund Ofatumumab Arzerra
08.02.04 Formulary Cancer Drugs Fund Olaparib Lynparza
03.04.02 Formulary Cancer Drugs Fund Omalizumab Xolair
05.03.03.02 Formulary Cancer Drugs Fund Ombitasvir - Paritaprevir - Ritonavir Viekirax
08.01.05 Formulary Cancer Drugs Fund Paclitaxel - Albumin Bound Formulation Abraxane
05.03.05 Formulary Cancer Drugs Fund Palivizumab Synagis
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.05 Non Formulary Cancer Drugs Fund Panobinostat Farydak
06.06.01 Non Formulary Cancer Drugs Fund Parathyroid Hormone Preotact
06.05 Non Formulary Cancer Drugs Fund Pasireotide 
08.01.05 Formulary Cancer Drugs Fund Pazopanib Votrient
11.08.02 Non Formulary Cancer Drugs Fund Pegaptanib Sodium Macugen
09.01.06 Non Formulary Cancer Drugs Fund Pegfilgrastim Neulasta
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa Pegasys
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa ViraferonPeg
08.02.04 Formulary Cancer Drugs Fund Peginterferon Beta-1a Plegridy
06.05.01 Non Formulary Cancer Drugs Fund Pegvisomant Somavert
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
03.11 Formulary Cancer Drugs Fund Pirfenidone Esbriet
08.01.02 Formulary Cancer Drugs Fund Pixantrone 
09.01.07 Formulary Cancer Drugs Fund Plerixafor Mozobil
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
03.05.02 Formulary Cancer Drugs Fund Poractant Alfa Curosurf
05.02 Formulary Cancer Drugs Fund Posaconazole Noxafil
02.11 Formulary Cancer Drugs Fund Protein C Concentrate Ceprotin
02.11 Formulary Cancer Drugs Fund Prothrombin Complex Concentrate  Octaplex
08.03.04.02 Formulary Cancer Drugs Fund Radium-223 dichloride 
05.03.01 Formulary Cancer Drugs Fund Raltegravir Isentress
08.01.05 Non Formulary Cancer Drugs Fund Ramucirumab Cyramza
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis
10.01.04 Formulary Cancer Drugs Fund Rasburicase Fastertec
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga
05.03.05 Formulary Cancer Drugs Fund Ribavirin Rebetol
05.03.05 Formulary Cancer Drugs Fund Ribavirin Copegus
05.01.07 Formulary Cancer Drugs Fund Rifaximin Targaxan
02.05.01 Non Formulary Cancer Drugs Fund Riociguat Adempas
08.02.03 Formulary Cancer Drugs Fund Rituximab MabThera
10.01.03 Formulary Cancer Drugs Fund Rituximab  MabThera
09.01.04 Formulary Cancer Drugs Fund Romiplostim Nplate
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi
09.04.01 Non Formulary Cancer Drugs Fund Sapropterin Dihydrochloride  Kuvan
05.03.01 Formulary Cancer Drugs Fund Saquinavir Invirase
10.01.03 Formulary Cancer Drugs Fund Sarilumab Kevzara
13.05.03 Formulary Cancer Drugs Fund Secukinumab Cosentyx
09.05.02.02 Formulary Cancer Drugs Fund Sevelamer Carbonate 2.4g sachets Renvela
09.05.02.02 Formulary Cancer Drugs Fund Sevelamer Hydrochloride  Renagel
02.05.01 Formulary Cancer Drugs Fund Sildenafil Revatio
05.03.03.02 Formulary Cancer Drugs Fund Simeprevir Olysio
20 Non Formulary Cancer Drugs Fund Sipuleucel- T 
08.02.02 Non Formulary Cancer Drugs Fund Sirolimus Rapamune
04.01.01 Formulary Cancer Drugs Fund Sodium Oxybate Xyrem
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir Sovaldi
06.05.01 Formulary Cancer Drugs Fund Somatropin  Zomacton
06.05.01 Formulary Cancer Drugs Fund Somatropin Omnitrope, Genotropin
06.05.01 Formulary Cancer Drugs Fund Somatropin Saizen
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent
20 Non Formulary Cancer Drugs Fund Taribavirin 
01.04.02 Non Formulary Cancer Drugs Fund Teduglutide Revestive
05.03.03.02 Formulary Cancer Drugs Fund Telaprevir Incivo
08.01.05 Formulary Cancer Drugs Fund Temozolomide Temodal
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel
08.02.04 Formulary Cancer Drugs Fund Teriflunomide Aubagio
06.06.01 Formulary Cancer Drugs Fund Teriparatide Forsteo
20 Non Formulary Cancer Drugs Fund TETRAHYDROBIOPTERIN Tablets 10 mg 
08.02.04 Formulary Cancer Drugs Fund Thalidomide Celgene
13.05.03 Formulary Cancer Drugs Fund Tildrakizumab Ilumetri
05.03.01 Formulary Cancer Drugs Fund Tipranavir Aptivus
08.01.05 Formulary Cancer Drugs Fund Tivozanib Fotivda®
05.01.04 Formulary Cancer Drugs Fund Tobramycin 
05.01.04 Formulary Cancer Drugs Fund Tobramycin inhaler TOBI Podhaler
10.01.03 Formulary Cancer Drugs Fund Tocilizumab RoActemra
10.01.03 Formulary Cancer Drugs Fund Tofacitinib citrate Xeljanz
06.05.02 Non Formulary Cancer Drugs Fund Tolvaptan Samsca
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Jinarc
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin
08.01.05 Non Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
20 Non Formulary Cancer Drugs Fund Treprostinil  
01.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara
13.05.03 Formulary Cancer Drugs Fund Ustekinumab Stelara
05.03.02.02 Formulary Cancer Drugs Fund Valganciclovir Valcyte
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
01.05.03 Formulary Cancer Drugs Fund Vedolizumab Entyvio
08.01.05 Formulary Cancer Drugs Fund Vemurafenib Zelboraf
11.08.02 Formulary Cancer Drugs Fund Verteporfin Visudyne
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge
05.02 Formulary Cancer Drugs Fund Voriconazole Vfend
08.01.05 Non Formulary Cancer Drugs Fund Vosaroxin Qinprezo
Oxfordshire Clinical Commissioning Group